In 2016 I co-founded www.BiopharmaTrend.com -- a now reputable analytical portal delivering industry news, case studies, reports, interviews with key opinion leaders, and hosting a unique interactive dashboard "The Landscape of Artificial Intelligence in Pharmaceutical R&D" available via subscription plans.

Later in 2020 we have joined forces with the UK-based analytical agency Deep Knowledge Analytics, a part of Deep Knowledge Group and co-founded Deep Pharma Intelligence. With the financial support from our partners and a business angel, we managed to gather a stellar team of experts and onboard global clients, including "big pharma", biotech companies, and investment organizations. 

I am also wearing another hat -- that one of technical and marketing executive at Enamine, a global chemical CRO and supplier of research chemicals for drug discovery. From 2015 to 2020, I had been helping the company to develop and grow www.EnamineStore.com -- the world's largest online shop of building blocks and screening compounds. I also managed commercial integrations (punchouts, APIs, etc), and digital marketing efforts. Check my Forbes article: “The Next Big Thing In The Life Sciences R&D Market: E-Commerce” to read about the role of ecommerce in the Life Sciences and some achievements of Enamine in this area. Since 2020, I switched completely to digital marketing and have been focusing on building integrity and trust for Enamine brand ever since.

Speaking about education, I've got MSc. in Inorganic Chemistry and Ph.D. in Physical Chemistry from Kyiv National Taras Shevchenko University (Ukraine) and spent a year at Temple University, in Philadelphia (Prof. Borguet Group) working on a NASA-funded project. 

During my research career, I participated in various research programs in Ukraine, the US, Germany, and Belgium, focusing on things like Coordination Chemistry, Bioinorganic Chemistry, Gas and Bio-sensors, and Nanotechnology. Here’s the list of research publications.

During my years in the pharmaceutical industry, I received training in Medicinal Chemistry, Computer-Aided Drug Design (CADD), and Molecular Biology. Since 2016 I have been focusing also on the application of Artificial Intelligence for Drug Discovery and Clinical Research, having developed a broad technical and strategic expertise in the area of strategy consulting and market research. A combination of expertise in chemistry and biology with a broad understanding of computational tools, AI, and digital tech, is among my unique competitive offerings for corporate and investment clients, when it comes to consulting projects in science writing, technology scouting, industry analytics, and startup advisory.